Cargando…
Genetic variants in de novo lipogenic pathway genes predict the prognosis of surgically-treated hepatocellular carcinoma
Over-expression of de novo lipogenesis (DNL) pathway genes is associated with the prognosis of various types of cancers. However, effects of single nucleotide polymorphisms (SNPs) in these genes on recurrence and death of hepatocellular carcinoma (HCC) patients after surgery are still unknown. A tot...
Autores principales: | Jiang, Hequn, Dai, Jingyao, huang, Xiaojun, Chen, Yibing, Qu, Ping, Li, Jibin, Yi, Cheng, Yang, Yefa, Zhang, Kejing, Huang, Qichao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379911/ https://www.ncbi.nlm.nih.gov/pubmed/25826294 http://dx.doi.org/10.1038/srep09536 |
Ejemplares similares
-
Genetic Variants in the EPCAM Gene Is Associated with the Prognosis of Transarterial Chemoembolization Treated Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Yu, Xiaohe, et al.
Publicado: (2014) -
High leukocyte mtDNA content contributes to poor prognosis through ROS-mediated immunosuppression in hepatocellular carcinoma patients
por: He, Xianli, et al.
Publicado: (2016) -
Celecoxib attenuates hepatosteatosis by impairing de novo lipogenesis via Akt‐dependent lipogenic pathway
por: Zhang, Cong, et al.
Publicado: (2022) -
Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients
por: Yuan, Peng, et al.
Publicado: (2014) -
Sestrin 2 confers primary resistance to sorafenib by simultaneously activating AKT and AMPK in hepatocellular carcinoma
por: Dai, Jimin, et al.
Publicado: (2018)